New Drug Shows Promise for Resistant Thyroid Cancer

SATURDAY, May 31, 2014 (HealthDay News) -- A new oral drug called lenvatinib looks promising as a treatment for a type of thyroid cancer that resists standard radiation, according to a later-stage clinical trial.

Pair of Pills Shows Promise for Recurrent Ovarian Cancer

SATURDAY, May 31, 2014 (HealthDay News) -- A combination of two new pills may nearly double the length of survival for patients with recurrent ovarian cancer, according to preliminary clinical trial results.

Experimental Drug May Extend Lung Cancer Survival, Study Suggests

SATURDAY, May 31, 2014 (HealthDay News) -- A new "targeted" therapy might help extend the lives of patients with advanced lung cancer who have a relapse after their initial treatment, a clinical trial suggests.